Prostaglandin signaling following seizures
癫痫发作后的前列腺素信号传导
基本信息
- 批准号:8487015
- 负责人:
- 金额:$ 8.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAffectAlzheimer&aposs DiseaseAppearanceArrestinsAstrocytesAwardBehavioralBody Weight decreasedBrainBrain InjuriesBudgetsChronicCyclic AMPCyclic AMP-Dependent Protein KinasesDataDevelopmentDinoprostoneDiseaseEncephalitisEnvironmentEpilepsyEventFundingGenesGoalsHippocampus (Brain)HumanInflammationInflammation MediatorsInflammatoryInflammatory ResponseInjuryKnockout MiceLaboratoriesLeadMediatingMentorsMicrogliaModelingModificationMolecularMolecular TargetMouse StrainsMultiple SclerosisMusN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNerve DegenerationNeurodegenerative DisordersNeuronsNeuropathogenesisNeurosciencesPathogenesisPathologyPathway interactionsPhasePhysiologicalPilocarpinePlayPostdoctoral FellowPreparationProsencephalonProstaglandin ReceptorProstaglandinsRNA InterferenceReactionReceptor ActivationRegulationResearchResearch EthicsResearch PersonnelResearch Project GrantsResearch ProposalsRodent ModelRoleScientistSeizuresSeriesSignal PathwaySignal TransductionSourceStatus EpilepticusStrokeSynapsesTechniquesTestingTherapeutic AgentsTrainingUnited States National Institutes of HealthUniversitiesWorkbasecareercyclooxygenase 2designdrug discoveryexcitotoxicityexperiencefunctional lossinnovationinsightkainatelentiviral-mediatedmacrophagemeetingsmortalitymouse modelnervous system disorderneurogenesisneuroinflammationneuropathologyneurotoxicneurotoxicitynovelnovel therapeuticsoxidative damagepost-doctoral trainingprostaglandin EP2 receptorpublic health relevancereceptorsmall moleculetherapeutic target
项目摘要
DESCRIPTION (provided by applicant): My career goal is to be an independent and successful scientist dedicated to understanding the cellular and molecular mechanisms of brain injuries, and ultimately developing novel therapeutic strategies. As a postdoctoral fellow, I wanted to study neuroinflammation and neurodegeneration by focusing on a major neurological disorder such as epilepsy, which led me to pursue postdoctoral training in Dr. Dingledine's laboratory. Up to now my major research focus has been to understand how prostaglandin signaling regulates chronic brain inflammation and degeneration during and after seizures. We have pursued two major avenues of research 1) to develop small molecules that selectively modify prostaglandin receptor EP2, and 2) to determine how these compounds affect the pathologies in mouse models of epilepsy. We have made significant progress toward both goals and have developed novel selective allosteric potentiators and antagonists for EP2 receptor. More recently, we have found that pharmacological inhibition of EP2 receptors after pilocarpine-induced status epilepticus in mice provides many beneficial effects including reductions in mortality, weight loss, functional loss, neuroinflammation and neurodegeneration. We also demonstrated that EP2 receptors regulate expression of a variety of pro-inflammatory genes in microglia likely via cAMP/Epac signaling. The current K99/R00 research proposal focuses on extending these findings to provide a more complete understanding of prostaglandin signaling in the neuropathogenesis following seizures, by taking advantage of this newly identified group of antagonists together with two conditional knockout mouse strains in which EP2 receptors are ablated either in forebrain neurons or microglia/macrophages. Successful completion of these studies will provide new insights on the regulation of inflammation and injury in epileptic brain that should be relevant to many other acute and chronic neurodegenerative disorders involving neuroinflammation with EP2 activation, including stroke, multiple sclerosis and Alzheimer's disease. Thus, this research could provide guidance to develop novel therapies for the treatment of those diseases. The research environment at Emory University is quite friendly, accommodating and collaborative. My expertise and experiences have prepared me to lead the proposed project, and my mentors (Dr. Raymond Dingledine and Dr. James McNamara) will provide mentoring, training, and oversight in epilepsy models, neuropathology, behavioral neuroscience, and guidance in project administration (e.g. staffing, regulatory issues and budget). I will also receive training from Dr. Kerry Ressler for lentiviral-mediated RNA interference in the mouse hippocampus, take courses on advanced neuroscience techniques, research ethics and lab management, and participate in scientific meetings. Overall, my proposal is very relevant to the goals of the NIH Pathway to Independence Award by providing technical and administrative training, establishing my own research projects, allowing me to pursue funding from the NIH, and ultimately facilitating my transition to an independent investigator.
描述(由申请人提供):我的职业目标是成为一名独立和成功的科学家,致力于了解脑损伤的细胞和分子机制,并最终开发新的治疗策略。作为一名博士后,我想通过专注于癫痫等主要神经系统疾病来研究神经炎症和神经变性,这促使我在丁格伦博士的实验室接受博士后培训。到目前为止,我的主要研究重点是了解前列腺素信号在癫痫发作期间和之后如何调节慢性脑炎症和变性。我们的研究主要有两个方向:1)开发小分子选择性修饰前列腺素受体EP2, 2)确定这些化合物如何影响癫痫小鼠模型的病理。我们已经在这两个目标上取得了重大进展,并开发了新的EP2受体选择性变构增强剂和拮抗剂。最近,我们发现在匹罗卡品诱导的小鼠癫痫持续状态后,药物抑制EP2受体提供了许多有益的影响,包括降低死亡率、体重减轻、功能丧失、神经炎症和神经变性。我们还证明,EP2受体可能通过cAMP/Epac信号传导调节小胶质细胞中多种促炎基因的表达。目前的K99/R00研究计划的重点是扩展这些发现,通过利用这组新发现的拮抗剂和两种条件敲除小鼠品系(其中EP2受体在前脑神经元或小胶质细胞/巨噬细胞中被切除),提供对癫痫发作后神经发病机制中前列腺素信号传导的更完整理解。这些研究的成功完成将为癫痫脑炎症和损伤的调节提供新的见解,这应该与许多其他急性和慢性神经退行性疾病有关,包括神经炎症与EP2激活,包括中风,多发性硬化症和阿尔茨海默病。因此,这项研究可以为开发治疗这些疾病的新疗法提供指导。埃默里大学的研究环境非常友好、包容和合作。我的专业知识和经验为我领导拟议的项目做好了准备,我的导师(Raymond Dingledine博士和James McNamara博士)将在癫痫模型、神经病理学、行为神经科学方面提供指导、培训和监督,并在项目管理方面提供指导(例如人员配备、监管问题和预算)。我还将接受Dr. Kerry Ressler关于慢病毒介导的RNA干扰小鼠海马的培训,学习高级神经科学技术、研究伦理和实验室管理的课程,参加科学会议。总的来说,我的提案通过提供技术和管理培训,建立我自己的研究项目,允许我从NIH获得资金,并最终促进我向独立研究者的过渡,与NIH独立之路奖的目标非常相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jianxiong Jiang其他文献
Jianxiong Jiang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jianxiong Jiang', 18)}}的其他基金
Targeting TRPC3 Channels for Epileptic Seizures
针对癫痫发作的 TRPC3 通道
- 批准号:
10531252 - 财政年份:2021
- 资助金额:
$ 8.92万 - 项目类别:
Targeting TRPC3 Channels for Epileptic Seizures
针对癫痫发作的 TRPC3 通道
- 批准号:
10353604 - 财政年份:2021
- 资助金额:
$ 8.92万 - 项目类别:
Inflammatory regulation of neurotrophin signaling in epileptogenesis
癫痫发生中神经营养蛋白信号传导的炎症调节
- 批准号:
10303038 - 财政年份:2018
- 资助金额:
$ 8.92万 - 项目类别:
Inflammatory regulation of neurotrophin signaling in epileptogenesis
癫痫发生中神经营养蛋白信号传导的炎症调节
- 批准号:
10058296 - 财政年份:2018
- 资助金额:
$ 8.92万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 8.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 8.92万 - 项目类别:
Operating Grants